John Greene, Director: Crispr Therapeutics CRSP Buy · Filed 25/02/28

Trade details

Type: Insider buy
Amount: $313,950
Shares · price: 7,000 sh · $44.85 a share
Held after: 7,000 sh
Stock: Crispr Therapeutics CRSP
Person: John GreeneDirector
Trade date: 25/02/26
Filed: 25/02/28
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 1 insiders

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/27~25/03/28

John Greene's recent trades

John GreeneEVP, CFO
SellDiscover Financial Services
Sell
Discover Financial Services
DFS
$3.7M
35,191 sh
$3.7M
Filed 24/01/30
Traded 24/01/26